What to Expect at Your First Clinical Trial Screening Visit

You've found a clinical trial that looks like a good fit. You've spoken to your doctor, read the summary, and expressed interest. The next step is the screening visit — and if you've never done one before, it's natural to feel uncertain about what's actually going to happen.

This guide walks you through the entire process so you can arrive prepared, confident, and ready to ask the right questions.

What Is a Screening Visit?

A screening visit is the research team's way of checking whether you're eligible to take part in a specific trial. It's not a commitment — it's an evaluation. Both sides are figuring out if the trial is a good match for you.

The visit is usually held at the hospital or research centre running the trial. It typically lasts between one and three hours, depending on how many tests are needed.

Key point: Attending a screening visit does not mean you've joined the trial. You are still free to say no at any point — even after all the tests are done.

Before the Visit: What to Bring

The research team will usually send you a list, but here's a reliable checklist:

Pro tip

If you take regular medication, bring the actual packaging or a photo of each box — including the dosage. It's more reliable than trying to remember from memory.

What Happens During the Visit

Every trial is different, but most screening visits follow a similar structure. Here's what to expect, step by step.

1

Welcome and introduction

You'll meet the research team — usually a research nurse or clinical research coordinator, and sometimes the principal investigator (the doctor leading the trial). They'll explain who they are, what the visit involves, and roughly how long it will take. This is a good time to mention any concerns or accessibility needs.

2

Detailed study explanation

The team will walk you through what the trial is testing, why it matters, and what participation would actually look like day to day. They'll explain the treatment or intervention, how often you'd need to visit, what tests are involved during the trial, and how long the whole thing lasts. If there's a chance you could receive a placebo, they'll tell you. Nothing should be vague or glossed over.

3

Informed consent

This is the most important part of the visit. You'll be given a consent document — often 10 to 20 pages — that covers the trial's purpose, procedures, risks, benefits, alternatives, your rights, and who to contact with questions. The team will go through it with you section by section.

Take your time. You do not have to sign anything on the day. Many people take the consent form home to read thoroughly and discuss with family or their GP before deciding.

4

Medical assessment

The research team will check whether you meet the trial's eligibility criteria. This usually involves:

  • Physical examination — blood pressure, heart rate, weight, height, and a general check
  • Blood tests — to check organ function, blood counts, and sometimes specific biomarkers
  • Urine sample — common for many trials
  • ECG (heart trace) — quick and painless, takes about five minutes
  • Review of your medical history — they'll go through your records in detail

Some trials may require additional tests like scans (CT, MRI, X-ray), breathing tests, or questionnaires about your symptoms and quality of life.

5

Questions and next steps

The team will ask if you have questions — and they genuinely want you to ask. There are no silly questions. They'll also explain what happens next: how and when you'll be told if you're eligible, when the trial would start if you qualify, and who your main contact will be throughout.

Questions Worth Asking

It helps to prepare questions in advance. Here are some that are always worth raising:

After the Visit

The research team will review your test results against the trial's eligibility criteria. This can take anywhere from a few days to a couple of weeks, depending on what tests were needed.

There are three possible outcomes:

  1. You're eligible and want to proceed — you'll be enrolled and given a schedule for your first treatment or baseline visit.
  2. You're eligible but decide not to participate — that's completely fine. No explanation needed, and your regular care continues unchanged.
  3. You're not eligible — this is common and not a reflection on you. Eligibility criteria are strict by design. The team may be able to suggest other trials that could be a better fit.

Remember: The screening visit is as much for you to evaluate the trial as it is for the team to evaluate you. Ask questions, take notes, and never feel pressured to decide on the spot.

A Few Things That Surprise People

Bottom line

A screening visit is a conversation, not a commitment. Go with an open mind, ask every question you have, and take the consent form home to read properly. Whatever you decide, you'll leave knowing more about your options than you did before — and that's always a win.

Ready to explore clinical trials?

Search thousands of actively recruiting trials by condition, location, and phase. Free, instant, and completely private.

Search Clinical Trials Read: Understanding Clinical Trials